-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Terns Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
- Terns Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.16M, a 70.5% decline year-over-year.
- Terns Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $15.9M, a 36.3% decline year-over-year.
- Terns Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25.5M, a 137% increase from 2022.
- Terns Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.8M, a 32.2% increase from 2021.
- Terns Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.15M, a 382% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)